Cargando…
Nitric oxide inhibits FTO demethylase activity to regulate N(6)-methyladenosine mRNA methylation
N(6)-methyladenosine (m(6)A) is the most abundant internal modification on eukaryotic mRNAs. Demethylation of m(6)A on mRNA is catalyzed by the enzyme fat mass and obesity-associated protein (FTO), a member of the nonheme Fe(II) and 2-oxoglutarate (2-OG)-dependent family of dioxygenases. FTO activit...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623363/ https://www.ncbi.nlm.nih.gov/pubmed/37866163 http://dx.doi.org/10.1016/j.redox.2023.102928 |
Sumario: | N(6)-methyladenosine (m(6)A) is the most abundant internal modification on eukaryotic mRNAs. Demethylation of m(6)A on mRNA is catalyzed by the enzyme fat mass and obesity-associated protein (FTO), a member of the nonheme Fe(II) and 2-oxoglutarate (2-OG)-dependent family of dioxygenases. FTO activity and m(6)A-mRNA are dysregulated in multiple diseases including cancers, yet endogenous signaling molecules that modulate FTO activity have not been identified. Here we show that nitric oxide (NO) is a potent inhibitor of FTO demethylase activity by directly binding to the catalytic iron center, which causes global m(6)A hypermethylation of mRNA in cells and results in gene-specific enrichment of m(6)A on mRNA of NO-regulated transcripts. Both cell culture and tumor xenograft models demonstrated that endogenous NO synthesis can regulate m(6)A-mRNA levels and transcriptional changes of m(6)A-associated genes. These results build a direct link between NO and m(6)A-mRNA regulation and reveal a novel signaling mechanism of NO as an endogenous regulator of the epitranscriptome. |
---|